Skip to main content

Arialys Therapeutics

La Jolla, United States

Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience.

$58.0M raised
Sep 2023
Seed

Top Investors

MPM CapitalAlexandria Venture InvestmentsJohnson & Johnson Innovation JJDCCatalys PacificAvalon BioVentures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Arialys Therapeutics

How much funding has Arialys Therapeutics raised?
Arialys Therapeutics has raised $58.0M in total funding. The most recent round was Seed. The last funding was announced in September 2023.
Who are Arialys Therapeutics's investors?
Arialys Therapeutics's investors include MPM Capital, Alexandria Venture Investments, Johnson & Johnson Innovation JJDC, Catalys Pacific, Avalon BioVentures.
Where is Arialys Therapeutics headquartered?
Arialys Therapeutics is headquartered in La Jolla, United States.
What does Arialys Therapeutics do?
Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience.
What stage is Arialys Therapeutics at?
Arialys Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Arialys Therapeutics — Funding & Investors." VCBacked, September 12, 2023, https://www.vcbacked.co/company/arialys-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2023). Arialys Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/arialys-therapeutics
Wikipedia (cite web)
{{cite web |title=Arialys Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/arialys-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .